Already Registered? Log In Now Not Registered?
Complete this form to enter the webcast. Already Registered?

(* indicates required field)

Complete this form to enter the webcast.
(* indicates required field)

  • LC
  • GC
  • LC-MS
  • GC-MS
  • Sample Preparation
  • Other
Read more about Agilent's privacy policy at https://www.agilent.com/home/privacy-policy.

By registering for this event, you agree to MJH Life Sciences ® Terms and Conditions, Privacy Policy, and understand your data will be used by MJH and its affiliates for amongst other things, alerting you to other services or products that you maybe interested in, and may be shared with or sold to third parties for their use, including possible contact with you through email or other communications, consistent with their respective privacy policy. If you do not agree to have your data used in this way, please contact info@mjhassoc.com.

*Denotes required.


LC/MS MAM Analysis of Adeno-Associated Virus Particles

This event is now available on demand. 
November 16th | Session 1: 7am PST|10am EST|3pm GMT
November 16th | Session 2: 11am PST|2pm EST|7pm GMT
November 17th | Session 3: 11am CST|12pm JST


Event Overview: 

Adeno-associated viruses (AAVs) are an important and emerging tool enabling the delivery of next-generation gene therapies. AAV critical quality attributes (CQAs) must be maintained for the safety and efficacy of the therapeutic, but can be challenging to analyze. This webinar will discuss several workflows for characterizing AAV CQAs, including product identity, post-translational modifications, and host cell proteins.


Key Learning Objectives: 
  • Method optimization parameters for separating capsid proteins
  • Technical challenges associated with AAV capsid analysis
  • Learn about the utility of mass spectrometry for AAV characterization

Who Should Attend: 
  • Analytical development scientists
  • CDMO and CRO lab personnel
  • Biopharmaceutical scientists in process development

For any technical questions please contact Jordan Ramesh: jramesh@mjhlifesciences.com


Wendi Hale
Wendi Hale
Biocolumns Product Manager
Agilent Technologies Inc.
Wendi Hale is a product manager for biocolumns at Agilent, supporting the cell and gene therapy market. Prior to this role, she was an LC/MS applications scientist focusing on biopharma applications. She received her PhD in analytical chemistry from the University of Michigan developing methods for analyzing proteins and peptides with LC–FT-ICR MS. Her postdoctoral work at the University of Geneva focused on phosphoproteomics.

Email: wendi.hale@agilent.com
LinkedIn: www.linkedin.com/in/wendi-hale